XML 140 R128.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-Based Compensation (Details) - Schedule of Stock-Based Compensation Plans - USD ($)
 3 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Schedule of Stock-Based Compensation Plans [Abstract]    
Number of Shares, Granted  
Average Exercise Price per Share, Granted  
Aggregate Intrinsic Value, Granted [1]  
Weighted Average Remaining Contractual Term in Years, Granted  
Number of Shares, Exercised  
Average Exercise Price per Share, Exercised  
Aggregate Intrinsic Value, Exercised [1]  
Weighted Average Remaining Contractual Term in Years, Exercised  
Number of Shares, Forfeited  
Average Exercise Price per Share, Forfeited  
Aggregate Intrinsic Value, Forfeited [1]  
Weighted Average Remaining Contractual Term in Years, Forfeited  
Number of Shares, Outstanding ending balance 3,314,128 3,314,128
Average Exercise Price per Share, Outstanding ending balance $ 1.3 $ 1.3
Aggregate Intrinsic Value, Outstanding ending balance [1]
Weighted Average Remaining Contractual Term in Years, Outstanding ending balance 4 years 3 months 18 days 4 years 2 months 12 days
Number of Shares, Exercisable ending Balance 549,958 549,958
Average Exercise Price per Share, Exercisable ending Balance $ 1.96 $ 1.96
Aggregate Intrinsic Value, Exercisable ending Balance [1]
Weighted Average Remaining Contractual Term in Years, Exercisable ending Balance, 3 years 9 months 18 days 3 years 6 months
[1] The intrinsic value of the stock options at March 31, 2024 is the amount by which the market value of the Company’s common stock of $1.04 as of March 31, 2024 exceeds the average exercise price of the option. As of March 31, 2024, the intrinsic value of the outstanding and exercisable stock options was nil.